These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 16546307)

  • 1. Safety of influenza vaccinations administered in nontraditional settings.
    D'Heilly SJ; Blade MA; Nichol KL
    Vaccine; 2006 May; 24(18):4024-7. PubMed ID: 16546307
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety of influenza A (H1N1) 2009 monovalent vaccines - United States, October 1-November 24, 2009.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2009 Dec; 58(48):1351-6. PubMed ID: 20010511
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and tolerability of cold-adapted influenza vaccine, trivalent, in infants younger than 6 months of age.
    Vesikari T; Karvonen A; Smith HM; Dunning A; Razmpour A; Saville MK; Gruber WC; Forrest BD
    Pediatrics; 2008 Mar; 121(3):e568-73. PubMed ID: 18299305
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Where adults reported receiving influenza vaccination in the United States.
    Singleton JA; Poel AJ; Lu PJ; Nichol KL; Iwane MK
    Am J Infect Control; 2005 Dec; 33(10):563-70. PubMed ID: 16330304
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rate of influenza vaccination and its adverse reactions seen in health care personnel in a single tertiary hospital in Korea.
    Lee CS; Lee KH; Jung MH; Lee HB
    Jpn J Infect Dis; 2008 Nov; 61(6):457-60. PubMed ID: 19050354
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monitoring vaccine safety during an influenza pandemic.
    Iskander J; Haber P; Herrera G
    Yale J Biol Med; 2005 Oct; 78(5):265-75. PubMed ID: 17132333
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety of trivalent inactivated influenza vaccines in adults: background for pandemic influenza vaccine safety monitoring.
    Vellozzi C; Burwen DR; Dobardzic A; Ball R; Walton K; Haber P
    Vaccine; 2009 Mar; 27(15):2114-20. PubMed ID: 19356614
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adverse events associated with intranasal influenza vaccine in the United States.
    Vasu N; Ghaffari G; Craig ET; Craig TJ
    Ther Adv Respir Dis; 2008 Aug; 2(4):193-8. PubMed ID: 19124371
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Attitudes and practices regarding influenza vaccination among emergency department personnel.
    Fernandez WG; Oyama L; Mitchell P; Edwards EM; St George J; Donovan J; Feldman JA
    J Emerg Med; 2009 Feb; 36(2):201-6. PubMed ID: 18281180
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Active surveillance for influenza vaccine adverse events: the integrated vaccine surveillance system.
    Newes-Adeyi G; Greece J; Bozeman S; Walker DK; Lewis F; Gidudu J
    Vaccine; 2012 Feb; 30(6):1050-5. PubMed ID: 22200501
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Universal influenza vaccination and live attenuated influenza vaccination of children.
    Glezen WP
    Pediatr Infect Dis J; 2008 Oct; 27(10 Suppl):S104-9. PubMed ID: 18820568
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influenza vaccination in pregnancy.
    Yeager DP; Toy EC; Baker B
    Am J Perinatol; 1999; 16(6):283-6. PubMed ID: 10586981
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adherence of mass vaccinators to timing guidelines for influenza vaccination.
    D'Heilly SJ; Lockman JL; Nichol KL
    Am J Prev Med; 2004 Jan; 26(1):46-50. PubMed ID: 14700712
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Adverse reactions after vaccination against influenza in chronically ill people].
    Gałaj A; Grześk G; Kuziemski A; Szadujkis-Szadurski L; Sinjab T
    Pol Merkur Lekarski; 2002 Jun; 12(72):496-9. PubMed ID: 12362669
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Death and serious illness following influenza vaccination: a multidisciplinary investigation.
    Rue-Cover A; Iskander J; Lyn S; Burwen DR; Gargiullo P; Shadomy S; Blostein J; Bridges CB; Haber P; Satzger RD; Ball R; Seward JF
    Pharmacoepidemiol Drug Saf; 2009 Jun; 18(6):504-11. PubMed ID: 19373848
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monitoring the safety of annual and pandemic influenza vaccines: lessons from the US experience.
    Iskander J; Broder K
    Expert Rev Vaccines; 2008 Feb; 7(1):75-82. PubMed ID: 18251695
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduced-dose influenza vaccine.
    Wyatt KN; Ryan GJ; Sheerin KA
    Ann Pharmacother; 2006 Sep; 40(9):1635-9. PubMed ID: 16835314
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of adverse events after influenza vaccination in hospital personnel.
    Scheifele DW; Bjornson G; Johnston J
    CMAJ; 1990 Jan; 142(2):127-30. PubMed ID: 2295029
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A cluster of deaths following influenza vaccination, Israel, 2006.
    Anis E; Leventhal A; Slater PE; Arbeli Y; Sivan Y; Berlovitz Y; Lev B; Israeli A
    J Public Health Policy; 2010 Sep; 31(3):318-23. PubMed ID: 20805804
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The comparison of adverse reactions to anti-influenza vaccines of split-vision and surface antigens].
    Bautista Rentero D; Tenías Burillo JM; Sabater Pons A; Pérez Bermúdez B; Zanón Viguer V
    Rev Esp Salud Publica; 1995; 69(6):463-8. PubMed ID: 8789358
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.